This cohort study found that statin use was associated with a reduced risk of hepatocellular carcinoma and hepatic decompensation in ...

FibroScan overestimated advanced fibrosis and cirrhosis in patients with class 3 obesity and metabolic dysfunction-associated steatotic liver disease.

Medically reviewed by Jay N. Yepuri, MD Metabolic dysfunction-associated steatohepatitis (MASH) is an advanced form of ...

The Hospital for Sick Children. "Newly uncovered mechanism could drive next-gen cystic fibrosis treatments." ScienceDaily. ScienceDaily, 13 March 2025. <www.sciencedaily.com / releases / 2025 / 03 / ...

Alcohol doesn’t just impact the liver, it wreaks havoc on the entire digestive system. From inflamed gums and acid reflux to ...

Medically reviewed by Jay N. Yepuri, MD FibroScan is the brand name for transient elastography, an abdominal ultrasound that ...

Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...

Researchers from Columbia University and the German Cancer Center have found that stellate cells—star-shaped liver cells long ...

Until now, doctors knew hepatic stellate cells mainly as drivers of liver fibrosis. The actual functions of this cell type have hardly been studied to date. Researchers have now determined that ...

THR-beta agonists are the only medication approved to treat metabolic dysfunction–associated steatohepatitis (MASH), a severe ...

Excessive alcohol consumption is a significant public health concern, responsible for approximately 6% of all deaths and contributing to 5.1% of the global disease burden. Alcohol use is a major risk ...

Fred Craves, Ph.D. to retire from Madrigal’s Board of Directors in July 2025CONSHOHOCKEN, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Madrigal ...